Skip to main content
. 2019 Feb 5;29(2):488–500.e2. doi: 10.1016/j.cmet.2018.09.022

Table 2.

Variants Identified in MC4R or Lipodystrophy Genes in Participants of European Ancestry

Gene Variant Protein Change Study MAF Global Gnomad MAF Known Functional Annotation Carrier BMI (mBMI) Carrier Twin BMI (mBMI) Non-carrier Twin BMI (mBMI) Twin Zygo-sity
Obesity

MC4R chr18:60371541 G/A p.Ser270Phe 0.04% 0.00% none 25.7 (26.1) 24.8 (24.7) N/A MZ
MC4R chr18:60372307 G/A p.Leu15Phe 0.04% 0.00% none 23 (22.6) 22.6 (22.4) N/A MZ
MC4R chr18:60371474 CA/C p.Met292fs 0.04% <0.003% (complete LOF)b 32.8 (26) N/A 28.8 (24.3) DZ
MC4R chr18:60371644 G/A p.Arg236Cys 0.04% 0.00% HGMD highC DM (not LOF)b 34.5 (32.3) 30 (27.5) N/A DZ
MC4R chr18:60372319 T/C p.Thr11Ala 0.04% <0.003% HGMD lowC DM (not LOF)b 36 (31.7) N/A N/A N/A
MC4R chr18:60371812 A/G p.Ser180Pro 0.04% <0.003% ClinVar LP (partial LOF)b 34.2 (30.2) 34.4 (33.5) N/A DZ
MC4R chr18:60371827 C/T p.Ala175Thr 0.04% 0.02% ClinVar P HGMD highC DM (partial LOF)b 29 (25.6) 28.5 (24.4) N/A MZ
MC4R chr18:60371842 T/C p.Ile170Val 0.04% 0.01% ClinVar P HGMD highC DM (partial LOF)b 22.6 (23.7) N/A 21.3 (24.7) DZ

Lipodystrophy

ZMPSTE24 chr1:40290870 G/GT p.Leu362fs 0.11% 0.03% ClinVar P 18 (18.9) N/A N/A N/A
ZMPSTE24 chr1:40290870 G/GT p.Leu362fs 0.11% 0.03% ClinVar P 22 (20.3) N/A N/A N/A
ZMPSTE24 chr1:40290870 G/GT p.Leu362fs 0.11% 0.03% ClinVar P 22.4 (26.1) N/A 22.6 (25.1) DZ
ZMPSTE24 chr1:40290870 GT/G p.Leu362fs 0.04% <0.003% not annotateda 30.7 (27.5) N/A 24.9 (24.1) DZ
AGPAT2 chr9:136673876 G/C p.Ala238Gly 0.04% 0.00% HGMD highC DM 20 (23.3) N/A N/A N/A
LIPE chr19:42401821 CCCCCCGCAGCCC CCGTCTA/C p.Val1068fs 0.04% 0.07% ClinVar P 23 (27.4) N/A N/A N/A
BSCL2 chr11:62692371 C/T c.863+5G>A 0.04% <0.003% ClinVar P 24 (29.9) N/A N/A N/A

MAF, minor allele frequency; HGMD highC DM, Human Gene Mutation Database high-confidence disease-causing mutation; lowC, low confidence; ClinVar LP, likely pathogenic; P, pathogenic; MZ, monozygotic; DZ, dizygotic. Each variant was only seen once in the unrelated participants of this study. See alignments in Figure S5.

a

This deletion at the same site as a lipodystrophy insertion has not previously been annotated.

b

Functional annotation according to Collet et al. (2017), where LOF = loss of function.